← Back to Search

Behavioural Intervention

Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

N/A
Waitlist Available
Research Sponsored by National Jewish Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Diagnosis of SLE
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to evaluate whether a short interactive video game device is associated with performance on standard measures of attention and problem solving in patients with systemic lupus erythematosus(SLE). The study is also designed to see if playing the video game for four weeks improves attention and problem solving in patients with SLE.

Eligible Conditions
  • Lupus
  • Systemic Lupus Erythematosus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Digit Symbol Substitution Scores
Change in Digit Vigilance Test Scores
Change in EVO performance threshold
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Project EVO Multi- TreatmentExperimental Treatment1 Intervention
Treatment group receives video game device treatment. Participant plays the game for 30 minutes a day, at least five days a week for four weeks.
Group II: ControlActive Control1 Intervention
No contact control

Find a Location

Who is running the clinical trial?

National Jewish HealthLead Sponsor
144 Previous Clinical Trials
317,314 Total Patients Enrolled
Akili Interactive Labs, Inc.Industry Sponsor
16 Previous Clinical Trials
2,022 Total Patients Enrolled
Novartis PharmaceuticalsIndustry Sponsor
2,921 Previous Clinical Trials
4,254,252 Total Patients Enrolled
~8 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top